Protein Kinase Inhibitors Cited by

Fol. Biol. 2006, 52, 137-148

https://doi.org/10.14712/fb2006052040137

Protein Kinase Inhibitors

Igor Shchemelinin, L. Šefc, E. Nečas

Institute of Pathological Physiology and Centre of Experimental Haematology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic

Received July 2006
Accepted September 2006

Crossref Cited-by Linking

Saeed Bahaa Ibrahim, Kumar Abhinav, Oghenemaro Enwa Felix, Almutairi Layla A., M Rekha M., Kumawat Rohit, Uthirapathy Subasini, Hulail Hanen Mahmod, Sharma Shilpa, Ravi Kumar M.: Interactions between lncRNAs and cyclins/CDKs complexes; key players in determining cancer cell response to CDKs inhibitors. Experimental Cell Research 2025, 445, 114406. <https://doi.org/10.1016/j.yexcr.2025.114406>
Duskova Klara, Cechakova Lucie, Plzakova Lenka, Sinkorova Zuzana, Kubelkova Klara: NATURAL IMMUNE BOOSTER IMUREGEN SIGNIFICANTLY AFFECTS THE PROLIFERATION OF TUMOR CELLS. MMSL 2019, 88, 106. <https://doi.org/10.31482/mmsl.2019.007>
Cozza G., Fortuna M., Meggio F., Sarno S., Kubbutat M. H. G., Totzke F., Schaechtele C., Pinna L. A., Olsufyeva E. N., Preobrazhenskaya M. N.: Hydrophobic Derivatives of Glycopeptide Antibiotics as Inhibitors of Protein Kinases. Biochemistry Moscow 2018, 83, 1222. <https://doi.org/10.1134/S0006297918100073>
Williams Victoria L., Cohen Philip R., Stewart David J.: Sorafenib\u2010induced premalignant and malignant skin lesions. Int J Dermatology 2011, 50, 396. <https://doi.org/10.1111/j.1365-4632.2010.04822.x>
Tasler Stefan, Müller Oliver, Wieber Tanja, Herz Thomas, Pegoraro Stefano, Saeb Wael, Lang Martin, Krauss Rolf, Totzke Frank, Zirrgiebel Ute, Ehlert Jan E., Kubbutat Michael H.G., Schächtele Christoph: Substituted 2-arylbenzothiazoles as kinase inhibitors: Hit-to-lead optimization. Bioorganic & Medicinal Chemistry 2009, 17, 6728. <https://doi.org/10.1016/j.bmc.2009.07.047>
London Cheryl A.: Tyrosine Kinase Inhibitors in Veterinary Medicine. Topics in Companion Animal Medicine 2009, 24, 106. <https://doi.org/10.1053/j.tcam.2009.02.002>
Wang Guannan, Matsuura Isao, He Dongming, Liu Fang: Transforming Growth Factor-\u03b2-inducible Phosphorylation of Smad3. Journal of Biological Chemistry 2009, 284, 9663. <https://doi.org/10.1074/jbc.M809281200>
SMITH KATHLEEN J., HALEY HEATHER, HAMZA SATE, SKELTON HENRY G.: Eruptive Keratoacanthoma-Type Squamous Cell Carcinomas in Patients Taking Sorafenib for the Treatment of Solid Tumors. Dermatologic Surgery 2009, 35, 1766. <https://doi.org/10.1111/j.1524-4725.2009.01289.x>
Dubreuil Patrice, Letard Sébastien, Ciufolini Marco, Gros Laurent, Humbert Martine, Castéran Nathalie, Borge Laurence, Hajem Bérengère, Lermet Anne, Sippl Wolfgang, Voisset Edwige, Arock Michel, Auclair Christian, Leventhal Phillip S., Mansfield Colin D., Moussy Alain, Hermine Olivier, Bauer Joseph Alan: Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT. PLoS ONE 2009, 4, e7258. <https://doi.org/10.1371/journal.pone.0007258>
London Cheryl A.: The Role of Small Molecule Inhibitors for Veterinary Patients. Veterinary Clinics of North America: Small Animal Practice 2007, 37, 1121. <https://doi.org/10.1016/j.cvsm.2007.06.003>